SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4e3c'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A29_A_TFPA154_1
(CALMODULIN)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 10 ALA A 170
LEU A 178
GLU A  61
LEU A  94
GLU A  97
None
1.44A 1a29A-4e3cA:
undetectable
1a29A-4e3cA:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BSX_A_T3A1_1
(PROTEIN (THYROID
HORMONE RECEPTOR
BETA))
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 12 ILE A 306
ALA A 212
LEU A 126
LEU A 265
ILE A 216
None
1.14A 1bsxA-4e3cA:
undetectable
1bsxA-4e3cA:
16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BSX_B_T3B2_1
(PROTEIN (THYROID
HORMONE RECEPTOR
BETA))
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 12 ILE A 306
ALA A 212
LEU A 126
LEU A 265
ILE A 216
None
1.14A 1bsxB-4e3cA:
undetectable
1bsxB-4e3cA:
16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_A_FFOA1293_2
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 SER A 498
GLU A 499
GLU A 495
None
0.54A 1eqbD-4e3cA:
undetectable
1eqbD-4e3cA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_C_FFOC3293_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 SER A 498
GLU A 499
GLU A 495
None
0.54A 1eqbB-4e3cA:
undetectable
1eqbB-4e3cA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PCG_B_ESTB2_1
(ESTROGEN RECEPTOR)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 10 LEU A 123
ALA A 121
GLU A 119
LEU A 117
LEU A 265
None
1.40A 1pcgB-4e3cA:
undetectable
1pcgB-4e3cA:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKN_A_RALA600_1
(ESTROGEN RECEPTOR
BETA)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
6 / 12 LEU A 125
THR A 124
ALA A 121
ILE A 151
GLY A 102
LEU A 153
None
1.41A 1qknA-4e3cA:
undetectable
1qknA-4e3cA:
17.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKT_A_ESTA600_1
(ESTRADIOL RECEPTOR)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 10 LEU A 123
ALA A 121
GLU A 119
LEU A 117
LEU A 265
None
1.35A 1qktA-4e3cA:
undetectable
1qktA-4e3cA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QWC_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 ARG A 118
VAL A 433
TRP A 434
None
1.10A 1qwcA-4e3cA:
undetectable
1qwcA-4e3cA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 12 ALA A  42
GLU A  61
CYH A  99
LEU A 136
HIS A 143
None
0.70A 1uwhA-4e3cA:
18.7
1uwhA-4e3cA:
17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
6 / 12 ALA A  42
LYS A  44
GLU A  61
CYH A  99
LEU A 136
HIS A 143
None
0.70A 1uwhB-4e3cA:
18.8
1uwhB-4e3cA:
17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VAG_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 ARG A 118
VAL A 433
TRP A 434
None
1.15A 1vagA-4e3cA:
undetectable
1vagA-4e3cA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZVI_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 ARG A 118
VAL A 433
TRP A 434
None
1.14A 1zviA-4e3cA:
undetectable
1zviA-4e3cA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VAV_F_CSCF1383_2
(ACETYL-COA--DEACETYL
CEPHALOSPORIN C
ACETYLTRANSFERASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 LEU A 479
MET A 636
MET A 517
None
0.80A 2vavF-4e3cA:
undetectable
2vavF-4e3cA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X2I_A_QPSA1050_2
(ALPHA-1,4-GLUCAN
LYASE ISOZYME 1)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 6 VAL A 235
TRP A 206
ARG A 220
THR A 217
None
1.47A 2x2iA-4e3cA:
undetectable
2x2iA-4e3cA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 MET A 280
VAL A 245
GLU A 240
None
0.78A 2x9gA-4e3cA:
undetectable
2x9gA-4e3cA:
17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_2
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 6 VAL A  73
ILE A 141
HIS A 143
ILE A 164
None
0.57A 3hegA-4e3cA:
17.7
3hegA-4e3cA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NRR_A_D16A520_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 12 ALA A 567
LEU A 594
PRO A 262
SER A 409
LEU A 440
None
1.03A 3nrrA-4e3cA:
undetectable
3nrrA-4e3cA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NRR_B_D16B520_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 12 ALA A 567
LEU A 594
PRO A 262
SER A 409
LEU A 440
None
0.97A 3nrrB-4e3cA:
undetectable
3nrrB-4e3cA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_C_RBVC601_1
(RNA POLYMERASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 11 LEU A 211
ASP A 145
LEU A 189
THR A 185
GLY A 184
None
1.44A 3sfuC-4e3cA:
undetectable
3sfuC-4e3cA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_2
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 8 VAL A  73
VAL A  74
ILE A 164
ASP A 166
None
0.55A 3wzeA-4e3cA:
17.9
3wzeA-4e3cA:
19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IKI_A_IMNA201_1
(TRANSTHYRETIN)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 LYS A 482
LEU A 479
ALA A 481
None
0.66A 4ikiA-4e3cA:
undetectable
4ikiA-4e3cA:
11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J24_A_ESTA600_1
(ESTROGEN RECEPTOR
BETA)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 12 LEU A 167
LEU A 146
ILE A 141
ILE A 142
LEU A 178
None
1.14A 4j24A-4e3cA:
undetectable
4j24A-4e3cA:
16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XJ7_D_ADND303_1
(5'/3'-NUCLEOTIDASE
SURE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 10 LEU A 303
LEU A 307
ASN A  72
SER A 131
ALA A 212
None
1.03A 4xj7C-4e3cA:
undetectable
4xj7D-4e3cA:
undetectable
4xj7C-4e3cA:
17.49
4xj7D-4e3cA:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZOW_A_CLMA500_0
(MULTIDRUG
TRANSPORTER MDFA)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
5 / 11 LEU A 108
LEU A 117
LEU A 146
ILE A 151
LEU A 133
None
0.75A 4zowA-4e3cA:
undetectable
4zowA-4e3cA:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_2_BEZ2801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 1
BEZ-LEU-LEU)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 4 LEU A 173
ARG A  67
ILE A 141
ILE A  64
None
1.03A 5dzk2-4e3cA:
undetectable
5dzkM-4e3cA:
undetectable
5dzkN-4e3cA:
undetectable
5dzk2-4e3cA:
9.52
5dzkM-4e3cA:
14.95
5dzkN-4e3cA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_V_BEZV801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 1
BEZ-LEU-LEU)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 4 ILE A 141
ILE A  64
ARG A  67
LEU A 173
None
1.07A 5dzkh-4e3cA:
undetectable
5dzkn-4e3cA:
undetectable
5dzkv-4e3cA:
undetectable
5dzkh-4e3cA:
14.95
5dzkn-4e3cA:
14.95
5dzkv-4e3cA:
9.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_X_BEZX801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 1
BEZ-LEU-LEU)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 5 ARG A  67
ILE A 141
GLY A 176
ILE A  64
None
0.89A 5dzki-4e3cA:
undetectable
5dzkj-4e3cA:
undetectable
5dzkx-4e3cA:
undetectable
5dzki-4e3cA:
14.95
5dzkj-4e3cA:
14.95
5dzkx-4e3cA:
9.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 ARG A 118
VAL A 433
TRP A 434
None
1.11A 5fvoA-4e3cA:
undetectable
5fvoA-4e3cA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XOO_A_ADNA506_1
(GLYCOSAMINOGLYCAN
XYLOSYLKINASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 6 LEU A 265
LYS A 275
GLU A 274
LEU A 259
None
1.38A 5xooA-4e3cA:
4.5
5xooA-4e3cA:
9.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_C_CHDC401_0
(BILE SALT HYDROLASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 8 ASN A 457
LEU A 361
ALA A 360
LEU A 354
None
0.88A 5y7pC-4e3cA:
undetectable
5y7pC-4e3cA:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_E_CHDE401_0
(BILE SALT HYDROLASE)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
4 / 8 ASN A 457
LEU A 361
ALA A 360
LEU A 354
None
0.85A 5y7pE-4e3cA:
undetectable
5y7pE-4e3cA:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NJ9_K_SAMK500_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA

(Homo
sapiens)
3 / 3 THR A 324
GLU A 442
ASN A 266
None
0.86A 6nj9K-4e3cA:
undetectable
6nj9K-4e3cA:
22.24